Verner Marc-André, Loccisano Anne E, Morken Nils-Halvdan, Yoon Miyoung, Wu Huali, McDougall Robin, Maisonet Mildred, Marcus Michele, Kishi Reiko, Miyashita Chihiro, Chen Mei-Huei, Hsieh Wu-Shiun, Andersen Melvin E, Clewell Harvey J, Longnecker Matthew P
Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Environ Health Perspect. 2015 Dec;123(12):1317-24. doi: 10.1289/ehp.1408837. Epub 2015 May 22.
Prenatal exposure to perfluoroalkyl substances (PFAS) has been associated with lower birth weight in epidemiologic studies. This association could be attributable to glomerular filtration rate (GFR), which is related to PFAS concentration and birth weight.
We used a physiologically based pharmacokinetic (PBPK) model of pregnancy to assess how much of the PFAS-birth weight association observed in epidemiologic studies might be attributable to GFR.
We modified a PBPK model to reflect the association of GFR with birth weight (estimated from three studies of GFR and birth weight) and used it to simulate PFAS concentrations in maternal and cord plasma. The model was run 250,000 times, with variation in parameters, to simulate a population. Simulated data were analyzed to evaluate the association between PFAS levels and birth weight due to GFR. We compared simulated estimates with those from a meta-analysis of epidemiologic data.
The reduction in birth weight for each 1-ng/mL increase in simulated cord plasma for perfluorooctane sulfonate (PFOS) was 2.72 g (95% CI: -3.40, -2.04), and for perfluorooctanoic acid (PFOA) was 7.13 g (95% CI: -8.46, -5.80); results based on maternal plasma at term were similar. Results were sensitive to variations in PFAS level distributions and the strength of the GFR-birth weight association. In comparison, our meta-analysis of epidemiologic studies suggested that each 1-ng/mL increase in prenatal PFOS and PFOA levels was associated with 5.00 g (95% CI: -21.66, -7.78) and 14.72 g (95% CI: -8.92, -1.09) reductions in birth weight, respectively.
Results of our simulations suggest that a substantial proportion of the association between prenatal PFAS and birth weight may be attributable to confounding by GFR and that confounding by GFR may be more important in studies with sample collection later in pregnancy.
在流行病学研究中,产前接触全氟烷基物质(PFAS)与较低出生体重有关。这种关联可能归因于肾小球滤过率(GFR),它与PFAS浓度和出生体重相关。
我们使用基于生理的妊娠药代动力学(PBPK)模型来评估在流行病学研究中观察到的PFAS与出生体重之间的关联有多少可能归因于GFR。
我们修改了一个PBPK模型以反映GFR与出生体重之间的关联(根据三项关于GFR和出生体重的研究估算),并使用它来模拟母体和脐带血浆中的PFAS浓度。该模型运行250,000次,参数有所变化,以模拟一个人群。对模拟数据进行分析,以评估由于GFR导致的PFAS水平与出生体重之间的关联。我们将模拟估计值与流行病学数据的荟萃分析结果进行了比较。
对于全氟辛烷磺酸(PFOS),模拟脐带血浆中每增加1 ng/mL,出生体重降低2.72 g(95%置信区间:-3.40,-2.04);对于全氟辛酸(PFOA),出生体重降低7.13 g(95%置信区间:-8.46,-5.80);足月时基于母体血浆的结果相似。结果对PFAS水平分布的变化以及GFR与出生体重关联的强度敏感。相比之下,我们对流行病学研究的荟萃分析表明,产前PFOS和PFOA水平每增加1 ng/mL,出生体重分别降低5.00 g(95%置信区间:-21.66,-7.78)和14.72 g(95%置信区间:-8.92, -1.09)。
我们的模拟结果表明,产前PFAS与出生体重之间的关联很大一部分可能归因于GFR的混杂作用,并且在妊娠后期进行样本采集的研究中,GFR的混杂作用可能更为重要。